A Phase I study of arsenic trioxide (Trisenox), ascorbic acid, and bortezomib (Velcade) combination therapy in patients with relapsed/refractory multiple myeloma
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Mitchell E Horwitz David Rizzieri Gwynn D Long Nelson J Chao Jon P Gockerman Cristina Gasparetto |
| Publication date | February 13, 2013 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |